26 (Bloomberg) -- Medtronic Inc. is contesting a U.S. Federal Trade Commission staff recommendation that would let Johnson & Johnson give Abbott Laboratories an exclusive license to a patented system for implanting coronary stents.
http://c.moreover.com/click/here.pl?r397020597
http://c.moreover.com/click/here.pl?r397020597